Linking Temporal Patterns of Modifiable Behaviors to Weight Loss Outcomes



Status:Enrolling by invitation
Conditions:Obesity Weight Loss
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:18 - 60
Updated:2/17/2019
Start Date:January 7, 2019
End Date:June 2022

Use our guide to learn which trials are right for you!

This study is designed as an observational trial. The objective of this study is to follow-up
with participants 3 years after completion of an 18-month comprehensive behavioral weight
loss intervention. Outcomes of interest include change in body weight, body composition,
physical activity, energy intake, and sleep. In addition, investigators will explore the
associations between current physical activity, sleep, and energy intake patterns and body
weight regulation.

A total of 170 participants were initially enrolled in the comprehensive behavioral weight
loss intervention.In this study, investigators will conduct a follow-up visit 3 years after
the completion of the intervention. Only participants who completed the behavioral weight
loss intervention will be enrolled in this study. Participants will undergo testing of body
weight, body composition, physical activity patterns, energy intake patterns, sleep patterns,
resting metabolic rate, and total daily energy expenditure.

Inclusion Criteria:

- Previous enrollment in standard behavioral weight loss intervention (NCT01985568)

- Age 20-60 (This age range has been selected based upon the participants enrolled in
the Parent Trial)

- Capable and willing to give informed consent

- Possess a smartphone to install and utilize the meal timing application

- Capable and willing to wear the Actigraph, ActivPAL and Actiwatch-2 for 24 hours/day
for 28 consecutive days

- Willing to complete the Total Daily Energy Expenditure (TDEE) assessment which
includes multiple urine collections and drinking stable water isotopes

Exclusion Criteria:

- Being considered unsafe to participate as determined by the study physician (Dr.
Catennaci)

- New diagnosis of a medical condition (not observed in the Parent Trial) which may
affect weight or energy metabolism (e.g. depression, CVD, diabetes, uncontrolled
hypertension, untreated thyroid, renal, hepatic diseases)

- Women who became pregnant after completing the Parent Trial

- Current use or use within the last 6 months of prescription or over-the-counter
medications known to affect appetite, weight, and sleep
We found this trial at
1
site
13001 E 17th Pl
Aurora, Colorado 80045
(303) 724-5000
University of Colorado Anschutz Medical Campus Located in the Denver metro area near the Rocky...
?
mi
from
Aurora, CO
Click here to add this to my saved trials